Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rectal Indomethacin as Early Treatment for Acute Pancreatitis (INDOMAP Trial): Study Protocol for a Multi-center, Double-blinded, Placebo-controlled, Randomized Clinical Trial

NCT03547232 is registered in ClinicalTrials.gov with Peking Union Medical College Hospital as lead sponsor.

NCT NCT03547232
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03547232 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rectal Indomethacin as Early Treatment for Acute Pancreatitis (INDOMAP Trial): Study Protocol for a Multi-center, Double-blinded, Placebo-controlled, Randomized Clinical Trial
Lead sponsor
Peking Union Medical College Hospital
Phase
Phase 4
Overall status
Recruiting
Start date
December 1, 2024
Completion date
December 1, 2028
Enrollment
1,504 (estimated)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

acute pancreatitis, complication, mortality rate, organ failure, multiple